From a Molecule to a Drug: Chemical Features Enhancing Pharmacological Potential
| Weitere Verfasser: |
Ribaudo, Giovanni
, [HerausgeberIn]
Orian, Laura , [HerausgeberIn] |
|---|---|
| Umfang/Format: |
1 online resource (234 pages). |
| Schlagworte: | |
| Online Zugang: |
DOAB: download the publication DOAB: description of the publication |
| LEADER | 04382namaa2201465ui 4500 | ||
|---|---|---|---|
| 001 | 003028680 | ||
| 005 | 20221228154802.0 | ||
| 003 | DE-2553 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220812s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-4754-1 | ||
| 020 | |a 9783036547534 | ||
| 020 | |a 9783036547541 | ||
| 040 | |a oapen |c oapen |b eng |d DE-2553 |e rda | ||
| 024 | 7 | |a 10.3390/books978-3-0365-4754-1 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a MMG |2 bicssc | |
| 100 | 1 | |a Ribaudo, Giovanni |e editor | |
| 264 | |b MDPI - Multidisciplinary Digital Publishing Institute, |c 2022. | ||
| 700 | 1 | |a Orian, Laura |e editor | |
| 700 | 1 | |a Ribaudo, Giovanni |e other | |
| 700 | 1 | |a Orian, Laura |e other | |
| 245 | 1 | 0 | |a From a Molecule to a Drug: Chemical Features Enhancing Pharmacological Potential |
| 300 | |a 1 online resource (234 pages). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a SARS-CoV-2 | ||
| 653 | |a benzoic acid derivatives | ||
| 653 | |a gallic acid | ||
| 653 | |a molecular docking | ||
| 653 | |a reactivity parameters | ||
| 653 | |a selenoxide elimination | ||
| 653 | |a one-pot | ||
| 653 | |a imine-enamine | ||
| 653 | |a reaction mechanism | ||
| 653 | |a DFT calculations | ||
| 653 | |a selenium | ||
| 653 | |a anti-inflammatory drugs | ||
| 653 | |a QSAR | ||
| 653 | |a pain management | ||
| 653 | |a cyclooxygenase | ||
| 653 | |a multitarget drug | ||
| 653 | |a cannabinoid | ||
| 653 | |a neuropathic pain | ||
| 653 | |a clopidogrel | ||
| 653 | |a NMR study | ||
| 653 | |a oxone | ||
| 653 | |a peroxymonosulfate | ||
| 653 | |a sodium halide | ||
| 653 | |a thienopyridine | ||
| 653 | |a drug discovery | ||
| 653 | |a precision medicine | ||
| 653 | |a pharmacodynamics | ||
| 653 | |a pharmacokinetics | ||
| 653 | |a coronavirus SARS-CoV-2 | ||
| 653 | |a COVID-19 | ||
| 653 | |a 3-chymotrypsin-like protease | ||
| 653 | |a pyrimidonic pharmaceuticals | ||
| 653 | |a molecular dynamics simulations | ||
| 653 | |a binding free energy | ||
| 653 | |a β-carrageenan | ||
| 653 | |a antioxidant activity | ||
| 653 | |a Box-Behken | ||
| 653 | |a extraction | ||
| 653 | |a Eucheuma gelatinae | ||
| 653 | |a physic-chemistry | ||
| 653 | |a rheology | ||
| 653 | |a quercetin | ||
| 653 | |a quercetin 3-O-glucuronide | ||
| 653 | |a cisplatin | ||
| 653 | |a nephrotoxicity | ||
| 653 | |a cytoprotection | ||
| 653 | |a lithium therapy | ||
| 653 | |a neurocytology | ||
| 653 | |a toxicology | ||
| 653 | |a neuroprotection | ||
| 653 | |a chemoinformatics | ||
| 653 | |a big data | ||
| 653 | |a methadone hydrochloride | ||
| 653 | |a pharmaceutical solutions | ||
| 653 | |a drug compounding | ||
| 653 | |a high performance liquid chromatography | ||
| 653 | |a stability study | ||
| 653 | |a microbiology | ||
| 653 | |a fucoidan | ||
| 653 | |a alginate | ||
| 653 | |a L-selectin | ||
| 653 | |a E-selectin | ||
| 653 | |a MCP-1 | ||
| 653 | |a ICAM-1 | ||
| 653 | |a THP-1 macrophage | ||
| 653 | |a monocyte migration | ||
| 653 | |a protein binding | ||
| 653 | |a breast milk | ||
| 653 | |a M/P ratio | ||
| 653 | |a statistical modeling | ||
| 653 | |a molecular descriptors | ||
| 653 | |a chromatographic descriptors | ||
| 653 | |a affinity chromatography | ||
| 653 | |a anti-ACE | ||
| 653 | |a anti-DPP-IV | ||
| 653 | |a gastrointestinal digestion | ||
| 653 | |a in silico | ||
| 653 | |a molecular dynamics | ||
| 653 | |a paramyosin | ||
| 653 | |a seafood | ||
| 653 | |a target fishing | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5830 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/91184 |7 0 |z DOAB: description of the publication |
| 590 | |a Online publication | ||
| 590 | |a ebookoa1222 | ||
| 590 | |a doab | ||
| 942 | |2 z |c EB | ||
| 999 | |c 3028680 |d 1432435 | ||
| 952 | |0 0 |1 0 |2 z |4 0 |6 ONLINE |7 1 |9 974319 |R 2022-12-28 14:48:02 |a DAIG |b DAIG |l 0 |o Online |r 2022-12-28 |y EB | ||
